Raul Insa Boronat (Raúl Insa)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Solid Phase Extraction

Peritoneal Dialysis

Emergency Department

Top Venues

British journal of clinical pharmacology

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

This page only lists publications with an associated author ORCID identifier.

Publications

Josep Gamez, Matilde Calopa, Esteban Muñoz, Aileen Ferré, Oscar Huertas, Kevin McAllister, Núria Reig, Catherine Scart-Grès, Raul Insa Boronat, Jaime Kulisevsky
A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease. British journal of clinical pharmacology (2022)
Josep Gamez, Matilde Calopa, Esteban Muñoz, Aileen Ferré, Oscar Huertas, Kevin McAllister, Núria Reig, Catherine Scart-Grès, Raul Insa Boronat, Jaime Kulisevsky
A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease. British journal of clinical pharmacology (2022)
Anna Nardi-Ricart, Isaac Nofrerias-Roig, Marc Suñé-Pou, Pilar Pérez-Lozano, Montse Miñarro-Carmona, Encarnación García-Montoya, Josep R Ticó-Grau, Raul Insa Boronat, Josep Maria Suñé-Negre
Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone's Particle Size on Sustained Release. Pharmaceutics 12 (7) (2020)
Josep Gamez, Maria Salvadó, Núria Reig, Pilar Suñé, Carlos Casasnovas, Ricardo Rojas-García, Raul Insa Boronat
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 26 (2) (2019)